J Kevin Buchi's Net Worth
$10.1 Million
Who is J Kevin Buchi?
J Kevin Buchi has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, TETRALOGIC PHARMACEUTICALS Corp, ZIOPHARM ONCOLOGY INC, Alexza Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Benitec Biopharma Inc., Ampio Pharmaceuticals, Inc., CEPHALON INC, BIOSPECIFICS TECHNOLOGIES CORP, EPIRUS Biopharmaceuticals, Inc., IMPAX LABORATORIES INC, STEMLINE THERAPEUTICS INC, and ENCYSIVE PHARMACEUTICALS INC.
SEC CIK
J Kevin Buchi's CIK is 0001209726
Past Insider Trading and Trends
2006 was J Kevin Buchi's most active year for acquiring shares with 10 total transactions. J Kevin Buchi's most active month to acquire stocks was the month of November. 2011 was J Kevin Buchi's most active year for disposing of shares, totalling 24 transactions. J Kevin Buchi's most active month to dispose stocks was the month of November. 2013 saw J Kevin Buchi paying a total of $3,174,278.00 for 473,254 shares, this is the most they've acquired in one year. In 2006 J Kevin Buchi cashed out on 90,944 shares for a total of $4,584,803.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
InvestorJ Kevin Buchi used to own units in Common Stock but no longer holds any shares there.acquired a total of 4,666 shares in Dicerna Pharmaceuticals Inc, J also disposed a total of 4,666 shares of Dicerna Pharmaceuticals Inc equalling to $178,474.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.67K |
$38.25 | -$178,474.50 |
0
|
Dec 28
| |||
Form 4
|
∞
| 4.67K |
—
|
—
| 4.67K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TETRALOGIC PHARMACEUTICALS Corp No price found
President & CEOJ Kevin Buchi owns 330,714 units of Common Stock.acquired a total of 330,714 shares in TETRALOGIC PHARMACEUTICALS Corp at a cost of $2,213,796.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.54% | 5K |
$4.23 | $21,147.50 | 330.71K |
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| +1.56% | 5K |
$5.04 | $25,181.00 | 325.71K |
Jan 7
| |||
Form 4
| +1.58% | 5K |
$6.01 | $30,060.00 | 320.71K |
Dec 9
| |||
Form 4
| +3.27% | 10K |
$4.99 | $49,900.00 | 315.71K |
Dec 2
| |||
Form 4
| +3.38% | 10K |
$4.82 | $48,185.00 | 305.71K |
Nov 18
| |||
Form 4
| +3.50% | 10K |
$3.93 | $39,325.00 | 295.71K |
Nov 11
| |||
Form 4
|
∞
| 285.71K |
$7.00 | $1,999,998.00 | 285.71K |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83
InvestorJ Kevin Buchi owns 4,167 units of Common Stock which is worth $11,792.61.acquired a total of 4,167 shares in ZIOPHARM ONCOLOGY INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.17K |
—
|
—
| 4.17K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alexza Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $8.39
InvestorJ Kevin Buchi owns 262,072 units of Class A Common Stock which is worth $2,198,784.08. From 2018 to 2024 J Kevin Buchi acquired a total of 262,072 shares in Amneal Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.19% | 76.45K |
—
|
—
| 262.07K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +75.96% | 80.13K |
—
|
—
| 185.62K |
May 9 - May 10
| |||
Form 4
| +50.52% | 35.41K |
—
|
—
| 105.49K |
May 8 - May 9
| |||
Form 4
| +193.65% | 46.22K |
—
|
—
| 70.08K |
May 5 - May 6
| |||
Form 4
| +37.10% | 6.46K |
—
|
—
| 23.87K |
May 5 - May 7
| |||
Form 4
| +54.04% | 6.11K |
—
|
—
| 17.41K |
May 6 - May 8
| |||
Form 4
|
∞
| 11.3K |
—
|
—
| 11.3K |
May 4 - May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||